You are here:
mesalazine (Asacol)
Advice
Following an abbreviated submission
Mesalazine 800 mg modified release tablet (Asacol) is accepted for use in NHS Scotland for the maintenance of remission in ulcerative colitis and Crohn’s ileo-colitis.
At the recommended dose of up to 2.4g daily, the 800 mg strength allows halving of the pill burden compared with the 400 mg formulation at no extra cost.
Drug Details
| Drug Name: | mesalazine (Asacol) |
|---|---|
| SMC Drug ID: | 224/05 |
| Manufacturer: | Procter and Gamble |
| Indication: | Maintenance of remission in ulcerative colitis and Crohn's ileo-colitis |
| BNF Category: | |
| Sub Category: | 1.5 Chronic bowel disorders |
| Submission Type: | Abbreviated Submission |
| Status: | Accepted |
| Date Advice Published: | 11 February 2008 |